发明名称 |
Systems for factor VIII processing and methods thereof |
摘要 |
The present invention provides methods of reducing nonprocessed Factor VIII or a chimeric polypeptide comprising Factor VIII comprising co-transfecting in a host cell a polynucleotide encoding Factor VIII with a polynucleotide encoding a protein convertase, where the endogenous processing enzymes of the host cell are insufficient to convert all of the Factor VIII to its processed isoform; expressing a proprotein convertase from a second polynucleotide in the host cell; and reducing the nonprocessed Factor VIII by processing with said proprotein convertase. |
申请公布号 |
US9611310(B2) |
申请公布日期 |
2017.04.04 |
申请号 |
US201113809285 |
申请日期 |
2011.07.11 |
申请人 |
Bioverativ Therapeutics Inc. |
发明人 |
Low Susan C.;Peters Robert T. |
分类号 |
C07K14/755;C12N9/64;C12P21/06;C12N9/60 |
主分类号 |
C07K14/755 |
代理机构 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
代理人 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
主权项 |
1. A method for decreasing nonprocessed Factor VIII (FVIII) in a culturing medium, comprising contacting a nonprocessed FVIII polypeptide expressed from a polynucleotide in a host cell with proprotein convertase subtilisin/kexin type 5 (PC5),
wherein the PC5 is expressed from a second polynucleotide in the host cell expressing the FVIII, wherein the host cell is a mammalian cell, and wherein the PC5 processes the nonprocessed FVIII polypeptide to a processed FVIII polypeptide, which comprises a FVIII heavy chain and a FVIII light chain associated by a non-covalent bond. |
地址 |
Waltham MA US |